Results 21 to 30 of about 6,314 (165)

Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models [PDF]

open access: yesVaccines
Background: The majority of antigen-based SARS-CoV-2 (SCV2) vaccines utilized in the clinic have had the Spike protein or domains thereof as the immunogen.
Jacob Meza   +16 more
doaj   +3 more sources

Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19

open access: yesFrontiers in Microbiology, 2022
The ongoing SARS-CoV-2 pandemic has shocked the world due to its persistence, COVID-19-related morbidity and mortality, and the high mutability of the virus.
Jiantao Zhang   +14 more
doaj   +3 more sources

A novel diG motif in ORF3a protein of SARS-Cov-2 for intracellular transport

open access: yesFrontiers in Cell and Developmental Biology, 2022
The ongoing SARS-CoV-2/COVID-19 pandemic caused a global public health crisis. Yet, everyone’s response to SARS-CoV-2 infection varies, and different viral variants confer diverse pathogenicity. Thus, it is imperative to understand how viral determinants
Ruth Cruz-Cosme   +12 more
doaj   +3 more sources

SARS-CoV-2 ORF3a Interacts and Stabilizes HMOX1 Expression and Function [PDF]

open access: yes, 2023
This thesis describes the interaction between SARS-CoV-2 Open Reading Frame 3a (ORF3a) and the Heme Oxygenase 1 (HMOX1). SARS-CoV-2 is a novel coronavirus and the causative agent of COVID-19, the highly contagious infection behind the 2019 COVID-19 ...
Jones, Naomi X
core   +2 more sources

Epitope mapping of ORF3a Protein SARS-CoV-2 in Indonesia through computational study [PDF]

open access: yesJournal of Tropical Life Science, 2022
In Indonesia, the vaccine for SARS-CoV-2 is still being developed. ORF3a protein of SARS-CoV-2 could be a potential peptide to be used in the vaccine, therapeutic antibodies, and diagnostic kit development. We used the computational approach in designing
Hartiyowidi Yuliawuri   +1 more
doaj   +2 more sources

D155Y substitution of SARS-CoV-2 ORF3a weakens binding with Caveolin-1 [PDF]

open access: yesComputational and Structural Biotechnology Journal, 2022
The clinical manifestation of the recent pandemic COVID-19, caused by the novel SARS-CoV-2 virus, varies from mild to severe respiratory illness. Although environmental, demographic and co-morbidity factors have an impact on the severity of the disease ...
Suchetana Gupta   +7 more
doaj   +3 more sources

The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins

open access: yeseLife, 2023
The severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and SARS-CoV-1 accessory protein Orf3a colocalizes with markers of the plasma membrane, endocytic pathway, and Golgi apparatus.
Alexandria N Miller   +13 more
doaj   +6 more sources

The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes [PDF]

open access: yesCell Discovery, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the ongoing coronavirus disease 2019 pandemic. How SARS-CoV-2 regulates cellular responses to escape clearance by host cells is unknown.
Yabin Zhang   +7 more
doaj   +3 more sources

SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle

open access: yesNature Communications
SARS-CoV-2, the causative agent of COVID-19, uses the host endolysosomal system for entry, replication, and egress. Previous studies have shown that the SARS-CoV-2 virulence factor ORF3a interacts with the lysosomal tethering factor HOPS complex and ...
Kshitiz Walia   +7 more
doaj   +2 more sources

Prediction of interactions between the SARS-CoV-2 ORF3a protein and small-molecule ligands using the AND-System cognitive platform, graph neural networks, and molecular [PDF]

open access: yesВавиловский журнал генетики и селекции
In recent years, artificial intelligence methods based on the analysis of heterogeneous graphs of biomedical networks have become widely used for predicting molecular interactions.
T. V. Ivanisenko   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy